drugset
drugset / Trial / NCT00350844

Hydroxyurea for Children and Young Adults With Sickle Cell Disease and Pulmonary Hypertension

NCT00350844 ↗

Phase 1/2 Terminated 6 enrolled Ann & Robert H Lurie Children's Hospital of Chicago
NaSingle-groupOpen-labelTreatment

Summary

The goal of this study is to test the hypothesis that hydroxyurea is effective for the specific treatment of secondary pulmonary hypertension found on screening in children and young adults with sickle cell disease.

Timeline

Start
2006-07
Primary completion
2008-06
Completion
2008-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydroxyurea Other / unclassified 20 mg/kg —

Indications

pulmonary hypertension sickle cell disease